Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
May 23, 2024 08:47 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, May 23, 2024 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA – May 23, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and...
Brooklyn Law School Announces New Fagen Professorship
May 22, 2024 08:00 ET
|
Brooklyn Law School
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Brooklyn Law School announced today the new Fagen Professorship, which was created through a major gift from Les Fagen, a longtime member of Brooklyn Law...
Pax8 and Perception Point Announce New Partnership
May 21, 2024 09:00 ET
|
Pax8
DENVER, May 21, 2024 (GLOBE NEWSWIRE) -- Pax8, the leading cloud commerce marketplace, today announced its partnership with Perception Point, providing partners with cutting-edge security solutions...
Novo Nordisk A/S - share repurchase programme
May 17, 2024 10:20 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 17 May 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16...
NeoVolta CEO Ardes Johnson Gives Expert Testimony to the US International Trade Commission Advising on Favorable Domestic Renewable Energy Policies
May 17, 2024 08:45 ET
|
NeoVolta Inc.
SAN DIEGO, May 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: NEOV) – NeoVolta Inc., a San-Diego based leader in smart energy storage solutions, announces that Ardes Johnson, CEO of NeoVolta, Inc. was...
Dental Bone Graft Substitutes Market is Expected to Reach $1.8 billion | MarketsandMarkets™
May 17, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 17, 2024 (GLOBE NEWSWIRE) -- Dental Bone Graft Substitutes market in terms of revenue was estimated to be worth $1.3 billion in 2024 and is poised to reach $1.8 billion by 2029, growing...
Pax8 Launches Pax8 Tech for Nonprofit
May 15, 2024 11:00 ET
|
Pax8
DENVER, May 15, 2024 (GLOBE NEWSWIRE) -- Pax8, the leading cloud commerce marketplace, today announced Pax8 Tech for Nonprofit, a new global program built for nonprofit organizations and the IT...
Dr. Bob Meyer D.C. Legacy in Sports Medicine Continues to Shine Bright: A Testament to Excellence
May 15, 2024 10:00 ET
|
Spinal Rehab Sports Medicine
AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- In the fast-paced world of sports medicine, few names command as much respect and admiration as Dr. Bob Meyer, D.C. With a career spanning decades,...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
May 15, 2024 07:23 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons...
Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial
May 13, 2024 11:49 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 13 May 2024 – Novo Nordisk today announced the headline results from the FRONTIER 2 trial, a pivotal phase 3a, 26-week open-label, randomised, controlled, multi-arm trial in 254...